This volume comprises the investigation of factors that may predict the response to treatment, outcome, and survival by exploring:

design considerations in molecular epidemiology, including:

• case-only
• family-based
• approaches for evaluation of genetic susceptibility to exposure and addiction pharmacogenetics
• incorporation of biomarkers in clinical trials

measurement issues in molecular epidemiology, including

• DNA biosampling methods
• principles for high-quality genotyping
• haplotypes
...